Domperidone for better blood sugar control in type 1 diabetes
Treatments studied
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests if domperidone, a medicine that helps the stomach empty faster, can improve blood sugar levels in people with type 1 diabetes who have slow stomach emptying but few symptoms. If you have type 1 diabetes, use an insulin pump or multiple daily injections, and have a continuous glucose monitor (CGM), this study might be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 74 years old
- You have had type 1 diabetes for more than 5 years
- You use insulin injections (multiple daily) or an insulin pump with a continuous glucose monitor (CGM)
- Your blood sugar is in the target range (70-180 mg/dL) less than 60% of the time, or your blood sugar swings a lot
- You have few or no symptoms of slow stomach emptying (like nausea or bloating)
- You do not have severe kidney disease, certain heart conditions, or take medicines that affect heart rhythm
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether domperidone can help people whose stomach or reflux symptoms did not improve with usual treatments. It focuses on symptoms like slow stomach emptying, hard-to-control acid reflux, or severe indigestion.
This trial looks at whether domperidone can help people ages 12–21 with symptoms from stomach not moving well when usual treatments haven’t worked. It’s designed for cases where other causes have been ruled out and patients are monitored for possible heart and hormone side effects.
This study tests a new way to give insulin directly into the abdomen (intraperitoneal) for people with type 1 diabetes. It will check how safe and effective a single dose is over 12 hours, using a special procedure to keep blood sugar stable (clamp).
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This trial tests an oral insulin capsule (ORMD-0801) for people with type 2 diabetes. It aims to see if the capsule can help control blood sugar safely, possibly offering an alternative to injections.
This Phase 2 study tests whether metoclopramide can help people with type 1 diabetes better notice when their blood sugar is getting too low. If low-blood-sugar warning is unreliable for you, this could help improve safety and control.
Hear when a new Type 1 Diabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.